ProMab

Company Overview

Promab is a biotechnology company headquartered in Richmond, California, USA. Founded in 2001, Promab specializes in the discovery and development of monoclonal antibodies (mAbs) and other biologics for research, diagnostic, and therapeutic applications. With a focus on innovation, quality, and customer satisfaction, Promab has established itself as a trusted partner for academic researchers, biotechnology companies, and pharmaceutical organizations worldwide.

Promab utilizes cutting-edge technologies and proprietary platforms to generate high-affinity monoclonal antibodies against a wide range of targets, including proteins, peptides, small molecules, and post-translational modifications. Promab offers custom antibody development services tailored to the specific needs of its customers. From antigen design and immunization to antibody screening and characterization, Promab’s team of experienced scientists provides comprehensive support throughout the antibody development process, ensuring the generation of high-quality antibodies with desired specificity and affinity. Promab develops and commercializes diagnostic antibodies and assay kits for use in research, clinical diagnostics, and drug development. These products enable the detection, quantification, and localization of biomarkers, proteins, and other analytes in biological samples, facilitating disease diagnosis, prognosis, and monitoring.

Company's Business Segments

• Biotechnology : The company develops and commercializes recombinant proteins, antibodies, and engineered cell lines to provide advanced research, diagnostic products, and services for the global biomedical research community.